{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_000064.3:c.2019G>T",
          "cDNA Change": {
            "transcript": "NM_000064.3",
            "ref": "G",
            "alt": "T",
            "position": "2019"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "703"
          },
          "Description in input context": "c.2019G>T (p.G703S)"
        },
        {
          "HGVS": "NM_000064.3:c.2020A>T",
          "cDNA Change": {
            "transcript": "NM_000064.3",
            "ref": "A",
            "alt": "T",
            "position": "2020"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "703"
          },
          "Description in input context": "c.2020A>T (p.A703T)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Autosomal Dominant Parkinson's Disease",
    "MONDO": "MONDO:0000146"
  },
  "Experiment Method": [
    {
      "Assay Method": "Binding Assay",
      "Material used": {
        "Material Source": "Recombinant LRRK2 protein",
        "Material Name": "LRRK2 recombinant protein",
        "Description": "Binding assays were performed using recombinant LRRK2 protein."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000064.3:c.2019G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced binding affinity",
          "Result Description": "Binding affinity decreased by 40% for the variant NM_000064.3:c.2019G>T."
        },
        {
          "Variant": "NM_000064.3:c.2020A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced binding affinity",
          "Result Description": "Binding affinity decreased by 35% for the variant NM_000064.3:c.2020A>T."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Binding affinity greater than 80% for the wild-type protein.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Binding affinity less than 50% for the variant.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Enzymatic Assay",
      "Material used": {
        "Material Source": "Recombinant LRRK2 protein",
        "Material Name": "LRRK2 recombinant protein",
        "Description": "Enzymatic assays were performed using recombinant LRRK2 protein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000064.3:c.2019G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced enzymatic activity",
          "Result Description": "Enzymatic activity decreased by 45% for the variant NM_000064.3:c.2019G>T."
        },
        {
          "Variant": "NM_000064.3:c.2020A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced enzymatic activity",
          "Result Description": "Enzymatic activity decreased by 40% for the variant NM_000064.3:c.2020A>T."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Enzymatic activity greater than 80% for the wild-type protein.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Enzymatic activity less than 50% for the variant.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "In Vitro Kinase Activity Assay",
      "Material used": {
        "Material Source": "Recombinant LRRK2 protein",
        "Material Name": "LRRK2 recombinant protein",
        "Description": "In vitro kinase assays were performed using recombinant LRRK2 protein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000064.3:c.2019G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced kinase activity",
          "Result Description": "Kinase activity decreased by 50% for the variant NM_000064.3:c.2019G>T."
        },
        {
          "Variant": "NM_000064.3:c.2020A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced kinase activity",
          "Result Description": "Kinase activity decreased by 45% for the variant NM_000064.3:c.2020A>T."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 protein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity greater than 80% for the wild-type protein.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity less than 50% for the variant.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}